Atlas Trials

Clinical Trial of Lurbinectedin (PM01183) in Platinum Resistant Ovarian Cancer Patients

Clinical trial NCT02421588 · COMPLETED

Trial details

NCT number
NCT02421588
Sponsor
PharmaMar
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2015-05-01
Primary completion
2018-10-12
Enrollment
442

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.